Jan 2017;28(1):368-375
Studies show that up to 66% of weight lost on GLP-1 medications can be regained within a year of stopping treatment
Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription $32.99 / 30 days cancel any time Subscribe to this journal Receive 52 print issues and online access $199.00 per year only $3.83 per issue Rent or buy this article Prices vary by article type from$1.95 to$39.95 Prices may be subject to local taxes which are calculated during checkout Nature 653 , 677-678 (2026) doi: References Jiang, S
She introduced tesofensine, a revolutionary peptide for weight loss that inhibits the reuptake of serotonin, noradrenaline, and dopamine, effectively suppressing appetite and boosting metabolic rate
By 2024, an estimated 12% of American adults reported taking a GLP-1 medication for diabetes, weight loss, or heart disease, according to data from the Kaiser Family Foundation